Ticker Scorecard - DVAX Basics Company: Dynavax Technologies Corporation IPO Date: February 19, 2004 Sector: Healthcare Industry: Biotech Market Cap: $1.69B Activated in VL: True Average Daily Range Avg Daily Range: $0.22 | 3.05% Avg Daily Range (30 D): $0.11 | 0.85% Avg Daily Range (90 D): $0.16 | 1.30% Institutional Daily Volume Avg Daily Volume: .89M Avg Daily Volume (30 D): 1.17M Avg Daily Volume (90 D): 1.48M Trade Size Avg Trade Size (Sh.): 127 Avg Trade Size (Sh.) (30 D): 82 Avg Trade Size (Sh.) (90 D): 97 Institutional Trades Total Inst.Trades: 4,106 Avg Inst. Trade: $2.34M Avg Inst. Trade (30 D): $2.96M Avg Inst. Trade (90 D): $3.3M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.92M Avg Closing Trade (30 D): $3.64M Avg Closing Trade (90 D): $3.88M Avg Closing Volume: 245.36K     News Sep 2, 2024 @ 8:15 PM Liver Fibrosis Market Is Expected to Reach USD 43.... Source: The Brainy Insights Aug 23, 2024 @ 2:00 PM Cancer Vaccines Market Size Expected to Reach USD ... Source: Towards Healthcare May 9, 2024 @ 6:15 AM Dynavax Technologies (DVAX) Q1 2024 Earnings Call ... Source: newsfeedback@fool.com (Motley Fool Transcribing) May 8, 2024 @ 9:20 PM Dynavax Technologies (DVAX) Reports Q1 Loss, Misse... Source: Zacks Equity Research May 7, 2024 @ 9:50 PM Myriad Genetics (MYGN) Reports Q1 Loss, Tops Reven... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $.15 $.13 $.09 Diluted EPS $.15 $.12 $.08 Revenue $ 260.81M $ 80.63M $ 73.8M Gross Profit $ $ $ Net Income / Loss $ 20.48M $ 17.59M $ 11.39M Operating Income / Loss $ -10.98M $ 10.08M $ 5.2M Cost of Revenue $ $ $ Net Cash Flow $ -35.17M $ 6.84M $ -19.53M PE Ratio 0.00     Splits Nov 10, 2014:   10:1